Tebra vs Elation Health

Side-by-side comparison of model-estimated upside.

Tebra

+1%

est. 2Y upside i

Healthcare

Rank

#1851

Sector

Healthcare Software

Est. Liquidity

~3Y

Data Quality

Data: Medium

The expected 2-year equity upside is ~1.2%, weighed down by high incumbent threat and likely dilution.

Last updated: July 19, 2026

Elation Health

-33%

est. 2Y upside i

HealthcareSeries D+

Rank

#3085

Sector

Healthcare Technology

Est. Liquidity

~4Y

Data Quality

Data: Medium

Expected 2-year common equity return is about -33% after a likely 20pt dilution and a $108.5M preference overhang, mainly because the 14.8x ARR entry price is above the 6x-12x public comp range.

Last updated: August 4, 2026

Upside Comparison

Expected Upside

Tebra
+1%
Elation Health
-33%

Disclaimer: These rankings are AI-generated estimates and do not constitute financial or career advice. Always conduct your own due diligence.